Abliva Management
Management criteria checks 2/4
Abliva's CEO is Ellen Donnelly, appointed in Feb 2021, has a tenure of 3.92 years. total yearly compensation is SEK7.03M, comprised of 54.1% salary and 45.9% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth SEK161.45K. The average tenure of the management team and the board of directors is 9 years and 8 years respectively.
Key information
Ellen Donnelly
Chief executive officer
SEK 7.0m
Total compensation
| CEO salary percentage | 54.1% |
| CEO tenure | 3.9yrs |
| CEO ownership | 0.02% |
| Management average tenure | 9yrs |
| Board average tenure | 8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -SEK 89m |
| Jun 30 2024 | n/a | n/a | -SEK 102m |
| Mar 31 2024 | n/a | n/a | -SEK 98m |
| Dec 31 2023 | SEK 7m | SEK 4m | -SEK 96m |
| Sep 30 2023 | n/a | n/a | -SEK 88m |
| Jun 30 2023 | n/a | n/a | -SEK 80m |
| Mar 31 2023 | n/a | n/a | -SEK 79m |
| Dec 31 2022 | SEK 6m | SEK 3m | -SEK 85m |
| Sep 30 2022 | n/a | n/a | -SEK 105m |
| Jun 30 2022 | n/a | n/a | -SEK 114m |
| Mar 31 2022 | n/a | n/a | -SEK 124m |
| Dec 31 2021 | SEK 4m | SEK 2m | -SEK 123m |
Compensation vs Market: Ellen's total compensation ($USD630.39K) is above average for companies of similar size in the UK market ($USD346.86K).
Compensation vs Earnings: Ellen's compensation has increased whilst the company is unprofitable.
CEO
Ellen Donnelly (50 yo)
3.9yrs
Tenure
SEK 7,029,000
Compensation
Dr. Ellen K. Donnelly, Ph D has been Chief Executive Officer at Abliva AB (publ) since February 03, 2021. She serves as Independent Director at Modus Therapeutics Holding Ab since 2020.Dr. Donnelly had be...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 3.9yrs | SEK 7.03m | 0.023% SEK 161.5k | |
| Deputy CEO | 11.1yrs | no data | 0.020% SEK 135.7k | |
| Chief Scientific Officer & VP of Discovery | 25yrs | SEK 247.00k | 0.046% SEK 316.9k | |
| Communications Officer & Lab Manager | no data | no data | no data | |
| Chief Medical Officer and VP of Preclinical & Clinical Development | 9yrs | no data | 0.053% SEK 367.3k | |
| Vice President of Clinical Operations | 1.9yrs | no data | 0.0013% SEK 9.3k | |
| Consultant | no data | no data | no data |
9.0yrs
Average Tenure
52yo
Average Age
Experienced Management: 0QDU's management team is seasoned and experienced (9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 8.8yrs | SEK 1.43m | 0.14% SEK 989.5k | |
| Independent Director | 8yrs | SEK 477.00k | 0.0085% SEK 58.8k | |
| Independent Director | 8yrs | SEK 438.00k | 0.0039% SEK 27.0k | |
| Independent Director | 6.8yrs | SEK 464.00k | no data | |
| Independent Director | 4.5yrs | no data | 14.71% SEK 102.2m |
8.0yrs
Average Tenure
64yo
Average Age
Experienced Board: 0QDU's board of directors are considered experienced (8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 19:26 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Abliva AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Patrik Ling | DNB Markets |
| Jonas Peciulis | Edison Investment Research |
| Ludvig Svensson | Penser Access |